Aleph Farms, an Israeli cellular agriculture company, has applied for regulatory approval in Switzerland to commercialize the first cultivated beef steaks under its Aleph Cuts brand.

This milestone comes as part of a strategic collaboration with Migros, Switzerland's leading food enterprise, which has played a crucial role in navigating the country's specific regulatory process.

Aleph Farms aims to expedite the scale-up and commercialization of Aleph Cuts by leveraging the expertise of Migros. The product offers a novel approach to meat production, increasing resilience and stability in the supply of animal proteins and fats.

Moreover, Aleph Farms plans to offer exclusive tasting experiences of Aleph Cuts in Singapore and Israel in limited quantities, subject to regulatory approvals. The company is actively pursuing similar regulatory clearances in various other countries, underscoring its commitment to complying with safety requirements and expanding the availability of its product on a global scale.

AnalystQuickTake: Compared to the US and Singapore, EU countries are not the most ideal for seeking regulatory approval for novel foods given their lengthier and rigorous process. Furthermore, while countries such as the Netherlands have taken a step toward commercialization, Italy has been calling for a ban on cultivated meats altogether. It is estimated to take between 12 and 24 months or even longer for the review and approval process for Aleph Farms, which can delay timelines for commercial launch.